Kit for detecting coronavirus RNA and method for detecting coronavirus RNA
A coronavirus and kit technology, applied in the field of molecular biology, can solve the problems of low specificity, false negatives, and inability to use rapid screening or detection, achieving high sensitivity, strong specificity, and satisfying clinical needs. The effect of rapid diagnosis and screening
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0027]This embodiment discloses a kit for detecting coronavirus RNA. This kit is used for efficient, rapid and specific detection of SARS-CoV-1 and SARS-CoV-2 coronavirus RNA to quickly and effectively distinguish positive samples from negative samples.
[0028]Specifically, the kit includes: nuclease Cas13a, Cas13a guide RNA for specific detection of SARS-CoV-1 gene sequence and SARS-CoV-2 gene sequence, RNA fluorescent probe, reverse transcriptase, DNA polymerase , T7 RNA polymerase, and buffer. Among them, the nuclease Cas13a is selected from bacteria, yeast, insects, mammalian cell lines or other biological protein expression systems. More specifically, the nuclease Cas13a is selected from organisms of the following genera: Ciliates, Listeria, Corynebacterium, Sartorella, Legionella, Treponema, Nematogen, Eubacteria Genus, Streptococcus, Lactobacillus, Mycoplasma, Bacteroides, Flavivola, Flavobacterium, Sphaerochaeta, Azospirillum, Gluconobacter, Neisseria, Roche, Parvibaculum, Sta...
Embodiment 2
[0034]Based on the kit disclosed in Example 1, this example discloses a method for highly specific detection of the coronavirus RNA of targeted genes, namely SARS-CoV-1 and SARS-CoV-2, based on the kit. This method is used for specific detection of SARS-CoV-1 and SARS-CoV-2.
[0035]The method for detecting coronavirus RNA includes the following steps:
[0036]The RNA of the sample to be tested is extracted, and reverse transcriptase is added for in vitro reverse transcription to synthesize complementary strand cDNA. The sample to be tested is selected from swabs of alveolar lavage fluid, saliva, blood, plasma, serum, feces, urine, sputum, mucus, lymph, synovial fluid, spinal fluid, cerebrospinal fluid, skin or mucous membrane, or Any or several combinations.
[0037]T7 RNA polymerase is added for re-transcription. Bacteriophage T7 RNA polymerase is a DNA-dependent RNA polymerase, which has strict specificity for its respective double-stranded promoters. This enzyme catalyzes 5'→3' synthesis...
Embodiment 3
[0042]Based on the kit and method disclosed in Example 1, this example discloses an application based on the aforementioned kit and method. This method is based on a kit and is used for specific detection of SARS-CoV-1 and SARS-CoV-2.
[0043]For the technical solutions of the same part of the kit and method disclosed in this embodiment as those in the first or second embodiment, please refer to the above, and will not be repeated here.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More